2023 has brought major changes in the clinical research technology industry. As research sites face a backlog of clinical trials, they’re becoming more selective with which studies they take on.

Introduction at Boao Super Hospital highlights China's evolving framework for international medical innovation and Guorun's ...

A retinal implant may offer selected patients with geographic atrophy limited form vision, while gene-based and cortical ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

Clinical trials are an essential element of the drug and clinical intervention development process. Different phases (I, II, III, and IV) of clinical trials are designed to ensure the safe and ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for ...

Fiza Shaukat is a native of Pakistan living in the United States. As a biomedical engineer, she was eager to improve her country’s medical devices and digital health strategies. She approached us in ...

In recent years, clinical research and development stakeholders have put tremendous effort into improving patient-centered clinical trials, where patients feel valued as partners in the processes and ...

Clinical research sites have faced unprecedented challenges in 2022. The resignation rate for healthcare workers continued to increase throughout 2021 and early 2022, reducing staff numbers to the ...

Digital pathology allows pathologists to interpret samples remotely from any location, provided there are pathology laboratories to process and digitize glass slides; this reduces risk and maintains ...